Pfizer and Valneva's Lyme disease vaccine shows over 70% efficacy

March 23, 2026 6:45 AM

Pfizer Inc. (NYSE: PFE) and Valneva SE (NASDAQ: VALN; Euronext Paris: VLA) reported that their investigational Lyme disease vaccine candidate ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found